Hypermobile Ehlers-Danlos syndrome (hEDS) is a lifelong connective tissue condition that mainly affects joints, skin, and sometimes internal organs. Many people first hear about hypermobile Ehlers-Danlos syndrome when frequent joint sprains, widespread pain, or easy fatigue start to disrupt daily activities like typing, sports, or carrying groceries. Common signs include very flexible (“double-jointed”) joints that are prone to partial or full dislocations, soft or mildly stretchy skin, slow-to-heal injuries, and pain that can range from intermittent aches to chronic, activity-limiting discomfort; some also experience dizziness on standing, digestive issues, or pelvic floor problems. Not everyone will have the same experience, and while hEDS is not considered life-shortening for most, complications like chronic pain, joint instability, and fatigue can be significant without tailored care. Treatment focuses on management rather than cure: targeted physical therapy to stabilize joints, bracing or taping when needed, pain and symptom management, and guidance on activity pacing, with care often coordinated by clinicians familiar with connective tissue disorders.
How many people live with Hypermobile ehlers-danlos syndrome?
Using a commonly cited overall rate of about 1 in 5,000 for all Ehlers-Danlos syndromes (EDS), that equals about 1.6 million people worldwide in 2023 and about 67,000 in the United States in 2023. Hypermobile Ehlers-Danlos syndrome (hEDS) is the most common subtype; if it accounts for roughly 60%–90% of EDS, that suggests about 1.0–1.4 million people worldwide and 40,000–60,000 in the United States—an estimate derived from the broader number, not a direct count.
Overview
Hypermobile ehlers-danlos syndromeSymptoms
Hypermobile Ehlers-Danlos syndrome features flexible joints that sprain or dislocate easily, joint pain, and stretchy skin that bruises easily. Many also have fatigue, delayed healing, dizziness standing, and gut issues. Early signs of hypermobile Ehlers-Danlos syndrome appear in childhood.
Outlook and prognosis
Many living with hypermobile Ehlers-Danlos syndrome can lead full, active lives, though joint pain, fatigue, and injuries may come and go. Symptoms often improve with tailored physical therapy, joint protection, and pain management. Early support and steady, realistic pacing help preserve long‑term function.
Causes and risk factors
Hypermobile Ehlers-Danlos syndrome appears largely genetic, often running in families in a dominant pattern, although a specific gene is usually unknown. Family history raises risk; hormones, joint overuse, injuries, deconditioning, and being female assigned at birth may influence severity.
Genetic influences
Genetics likely play a role in hypermobile Ehlers-Danlos syndrome (hEDS), but the exact gene changes are still unclear for most people. hEDS often runs in families, suggesting inherited susceptibility. Genetic testing rarely confirms hEDS; diagnosis relies on clinical evaluation.
Diagnosis
Diagnosis of hypermobile Ehlers-Danlos syndrome is clinical, using joint hypermobility scores and 2017 criteria plus family history. Genetic tests currently can’t confirm hEDS but help exclude other EDS types. Doctors may order imaging or labs to assess related issues.
Treatment and drugs
Treatment for hypermobile Ehlers-Danlos syndrome focuses on protecting joints, easing pain, and supporting daily function. Care often combines tailored physical therapy, bracing or taping during flares, joint-friendly exercise, and pain strategies. Some benefit from medications, pelvic floor therapy, and coordinated care from rheumatology, pain, and rehabilitation teams.
Symptoms
Hypermobile Ehlers-Danlos syndrome (hEDS) affects the body’s connective tissues, making joints more flexible and some tissues more easily strained. At home or work, frequent sprains, aching joints after light activity, or easy bruising may stand out. When people talk about early features of Hypermobile ehlers-danlos syndrome, they often mention joint instability and tired, sore muscles. Features vary from person to person and can change over time.
Joints move beyond the usual range and may feel loose or wobbly. This can make certain stretches easy but increases the risk of strains and sprains.
Joints can partially slip or fully dislocate, sometimes with a pop and sudden pain. Clinicians call this subluxation, which means a partial slip of the joint.
Achy, sore joints are common in hEDS, especially after routine tasks or long standing. Pain can be sharp with movement or a dull throb later in the day.
Muscles work harder to stabilize loose joints and can tire quickly. This may feel like heavy limbs or shakiness after short activity.
How people usually first notice Hypermobile ehlers-danlos syndrome?
Many people first notice hypermobile Ehlers-Danlos syndrome when joints move far past the usual range and seem to “give way,” leading to frequent sprains, dislocations, or pain after routine activities. In childhood or the teen years, the first signs of hypermobile Ehlers-Danlos syndrome may include being “double-jointed,” needing more time to recover after sports, easy bruising, or soft, stretchy skin that marks easily. Some are first flagged by a clinician during evaluation for chronic joint pain, repeated injuries, or symptoms like fatigue, dizziness on standing, or digestive issues that don’t have another clear cause.
Types of Hypermobile ehlers-danlos syndrome
Hypermobile Ehlers-Danlos syndrome (hEDS) doesn’t have officially recognized genetic subtypes yet, but symptoms often fall into clear patterns that affect day-to-day life in different ways. Daily life often makes the differences between symptom types clearer. Not everyone will experience every type, and what’s most troublesome can shift over time. When people ask about types of hypermobile Ehlers-Danlos syndrome, they’re usually looking for these common symptom categories rather than formal variants.
Joint instability
Joints feel loose and may sprain, sublux, or dislocate with everyday motions. Pain often flares after activity and improves with rest and targeted strengthening. Some notice joints give way on stairs or when lifting.
Chronic pain
Widespread aching or sharp, localized pain can persist even on low-activity days. Tender points around joints and muscles are common. Sleep and mood can worsen when pain is not well controlled.
Fatigue and stamina
Deep, non-refreshing tiredness can limit work, school, or social plans. Energy dips may follow flares, infections, or poor sleep. Pacing and gentle conditioning often help prevent crashes.
Skin and soft tissue
Skin may feel soft or velvety and bruise easily, with slow-healing or wide scars. Stretch marks can appear without big weight changes. Some notice frequent superficial injuries from minor bumps.
Autonomic symptoms
Dizziness, rapid heartbeat on standing, and brain fog can point to orthostatic intolerance or POTS. Symptoms improve when lying down and may worsen in heat or after large meals. Extra fluids, salt, and compression garments can help.
Gastrointestinal issues
Reflux, bloating, constipation, or alternating bowel habits are common. Symptoms may flare with stress or after certain foods. Gentle diet adjustments and bowel routines often reduce discomfort.
Pelvic and bladder
Pelvic floor weakness or prolapse can cause pressure, urinary urgency, or leakage. Some experience pain with intimacy or pelvic exams. Pelvic floor therapy can improve support and control.
Neuromuscular coordination
Poor proprioception can make balance and fine motor tasks harder. People may drop objects, trip, or feel clumsy during sports. Targeted balance and coordination training can build steadiness.
Allergy-like features
Flushing, hives, and food sensitivities can occur in some, sometimes labeled mast cell–related. Triggers include temperature shifts, fragrances, or certain foods. Antihistamines and trigger tracking may lessen flares.
Dental and jaw
Jaw clicking, pain, or locking can affect chewing and speech. Crowding, gum recession, and frequent mouth sores may occur. Soft-bite splints and targeted jaw exercises can ease strain.
Can I slow down the onset of symptoms?
There’s no strong evidence that lifestyle changes or medicines can delay when hypermobile Ehlers-Danlos syndrome (hEDS) symptoms first appear, because it’s a genetic condition. Still, regular low-impact activity and gentle strength work to support the joints, learning joint-safe movement with a physical therapist, avoiding extreme stretching and high-impact sports, balancing activity with rest, and good sleep are widely recommended to lower the risk of injuries and flare-ups. These steps can’t prevent hEDS, but starting early with guidance can help you stay active and keep symptoms more manageable over time.
What genetics can tell you about symptoms
In many people with hypermobile Ehlers-Danlos syndrome, changes in genes that guide collagen “scaffolding” make joints unusually stretchy, leading to frequent sprains, dislocations, and widespread joint pain. These same variations can also loosen supportive tissues, contributing to soft, easily bruised skin and fatigue.
Causes and risk factors
In hypermobile Ehlers-Danlos syndrome (hEDS), the main cause appears to be an inherited difference in connective tissue that makes ligaments and other soft tissues more stretch‑prone and joints more flexible. A specific gene has not yet been confirmed for most people with hEDS, but the condition often runs in families, and an affected parent has about a 1 in 2 chance of passing on the tendency. Risk factors for hypermobile Ehlers-Danlos syndrome include a family history of marked joint looseness or hEDS, with symptoms more often recognized in women and people assigned female at birth; joint looseness is generally greater in childhood, and hormonal shifts such as puberty, pregnancy, or menopause can change how symptoms appear. Environment and lifestyle don’t cause hEDS but can influence severity over time—repetitive joint strain, high‑impact or contact sports, deep or prolonged stretching, previous injuries, and low muscle strength may increase instability and pain, while balanced strength and joint‑friendly training can be protective. Some risks are modifiable (things you can change), others are non-modifiable (things you can’t).
What are the most common causes or risk factors?
The exact cause of hypermobile Ehlers-Danlos syndrome (hEDS) isn’t fully known, and no single gene explains most cases, but it clearly runs in families and is often passed from a parent to a child—with about a 50% chance for each child. Having a close relative with hEDS or with very loose joints, easy bruising, or fragile skin is the strongest risk factor. Non-genetic factors don’t cause hEDS itself, but symptoms may be more noticeable in people assigned female at birth, during puberty or pregnancy, or after injuries, and they often lessen with age as joints naturally stiffen.
Environmental and biological risk factors
For hypermobile Ehlers-Danlos syndrome (hEDS), most risk appears to come from body-based factors present from birth; environmental triggers are not clearly established. Doctors often group risks into internal (biological) and external (environmental). Current research suggests that while surroundings can influence when features are noticed, they have not been shown to cause hEDS.
In hEDS, connective tissues are looser and more stretchable from birth. This internal biology increases the chance of joint hypermobility and related features. It sets much of the baseline risk for hypermobile Ehlers-Danlos syndrome.
hEDS is identified more often in females, likely influenced by hormonal effects on ligaments. Periods of higher estrogen or progesterone can increase laxity, making early symptoms of hypermobile Ehlers-Danlos syndrome more noticeable. This pattern reflects recognition differences rather than a proven cause.
Children and teens naturally have more flexible joints, which can overlap with hEDS features. As tissues stiffen with age, hypermobility may be less obvious even when the underlying condition is present. Age can therefore affect when hEDS is recognized.
Baseline joint range can be higher in some populations, which may complicate assessment. Clinicians weigh skin, pain, and stability features in addition to flexibility when evaluating hEDS. This variation influences detection rather than the root biology.
Genetic risk factors
Genetics play a key role in hypermobile Ehlers-Danlos syndrome (hEDS), but researchers have not yet found a single causative gene. hEDS often runs in families in a pattern that looks autosomal dominant, meaning a parent can pass on a tendency toward joint hypermobility and related features. Risk is not destiny—it varies widely between individuals. Understanding genetic risk factors for hypermobile Ehlers-Danlos syndrome can help families plan for early evaluation if symptoms begin.
Family history: Many people with hEDS have close relatives with joint hypermobility or a confirmed hEDS diagnosis. Seeing similar features across generations suggests inherited risk.
Autosomal dominant pattern: hEDS often appears in several generations, consistent with about a 50% chance of passing on the tendency from an affected parent. This chance of inheritance does not predict how severe features will be in the child.
Variable expressivity: Features can look different even within the same family. One person may mainly have flexible joints, while another has frequent sprains, pain, or soft skin.
Incomplete penetrance: Some who inherit the risk show few or no clear features. Others develop early symptoms of hypermobile Ehlers-Danlos syndrome, such as frequent joint instability.
Polygenic influences: hEDS likely reflects the combined effect of many genes that each nudge connective tissue strength and how it is built and maintained. Several small changes together may add up to higher susceptibility.
Unknown causative genes: Unlike other EDS types with identified gene changes, the specific gene or genes for hEDS remain unknown. This is why diagnosis currently relies on clinical criteria rather than a single lab test.
Genetic testing limits: Standard genetic panels cannot confirm or rule out hEDS at this time. Testing may still help exclude other EDS subtypes with known genes.
Lifestyle risk factors
Daily habits don’t cause hypermobile Ehlers-Danlos syndrome, but they can shape how often symptoms flare and how intense they feel. In practical terms, certain choices can strain already-loose joints, amplify pain and fatigue, or unsettle digestion and blood pressure. Genes may set the foundation, but environment builds the house. Here’s how common lifestyle risk factors for hypermobile Ehlers-Danlos syndrome may influence day-to-day stability and comfort.
Repetitive jumping, sprinting, or contact sports can increase subluxations and sprains in already lax joints. Lower-impact movement is usually safer for keeping active without triggering flares.
Deep stretches and hyperextending poses can loosen connective tissue further and worsen instability. Gentle range-of-motion work is safer than pushing end ranges.
Long breaks from movement weaken the muscles that act like external braces for joints. Weaker support can raise the risk of pain, fatigue, and further joint slipping.
Not training core, hips, and shoulder girdle leaves joints without steady scaffolding. Targeted strengthening can improve alignment and reduce everyday micro-injuries.
Risk prevention
Hypermobile Ehlers-Danlos syndrome (hEDS) can’t be prevented, but you can lower the chance of sprains, dislocations, pain flares, and fatigue. Prevention is about lowering risk, not eliminating it completely. The focus is protecting joints, supporting muscles, caring for sensitive skin and nerves, and planning ahead for procedures or activity. Small, steady habits usually work better than big, short-lived changes.
Choose low‑impact activities like swimming, cycling, or walking on even ground. Avoid positions that push joints to their end range or “lock” them straight.
Build core, hip, and shoulder strength to help muscles act like extra joint support. Slow, controlled movements and balance work can improve stability over time.
Work with a therapist who understands hypermobility and teaches joint‑safe techniques. A tailored plan focuses on posture, proprioception, and gradual progression to prevent setbacks.
Break tasks into smaller chunks and alternate effort with rest to avoid overuse. Keep routines flexible so you can adjust on high‑symptom days.
Can you prevent Hypermobile ehlers-danlos syndrome?
You can’t prevent hypermobile Ehlers-Danlos syndrome (hEDS). It usually runs in families and is something you’re born with, but you can lower the risk of joint injuries and day-to-day flare-ups by strengthening muscles with guided exercise or physical therapy, protecting flexible joints during daily tasks, and avoiding over‑stretching or high‑impact sports. Healthy habits like staying active within your limits, keeping a steady weight, and not smoking can support overall joint health, though they don’t stop hEDS itself.
Transmission
Hypermobile Ehlers-Danlos syndrome (hEDS) is not contagious—you can’t catch it from someone or pass it through casual contact. It’s passed down in families.
Most often, hEDS follows an autosomal-dominant pattern, so if one parent has hEDS, each child has about a 50% chance of inheriting it. Features can vary widely even within the same family, and some people are the first in their family due to a new genetic change. Because the specific gene for hEDS hasn’t been confirmed in most cases, routine testing isn’t available, but a genetics visit can help explain the genetic transmission of hypermobile Ehlers-Danlos syndrome and family risks.
When to test your genes
Consider genetic testing if you have pronounced joint hypermobility with frequent dislocations, stretchy or fragile skin, poor wound healing, or a strong family history of similar features. Testing is also useful before major surgery, pregnancy, or starting high-impact sports to guide safer care. Talk with a genetics clinician; they can match the right test and interpret results.
Diagnosis
Hypermobile Ehlers-Danlos syndrome (hEDS) is identified by a pattern of flexible joints, recurring injuries, and skin or tissue features seen on exam. The diagnosis of Hypermobile Ehlers-Danlos syndrome is clinical, based on set criteria, and there isn’t a single confirmatory lab test for hEDS. Doctors usually begin with your story—what’s changed day to day—and a careful physical exam focused on joint movement and tissue signs. Tests are used mainly to check for other connective tissue conditions with similar features.
Your clinician asks about joint pain, frequent sprains or dislocations, and how symptoms affect work, school, and exercise. They also note fatigue, dizziness, or stomach issues that can travel with hEDS. Patterns over time help guide next steps.
The provider measures joint flexibility with nine simple maneuvers of the fingers, elbows, knees, and spine. A higher score suggests generalized joint hypermobility, with age-adjusted cutoffs used for children and adults. Scores are interpreted alongside your symptoms.
Clinicians look for a cluster of features like soft or mildly stretchy skin, easy bruising, hernias, pelvic organ prolapse, or piezogenic heel papules. Having several of these, plus joint hypermobility, raises the likelihood of hEDS. The overall pattern matters more than any single sign.
The exam notes skin feel (often soft/velvety), mild hyperextensibility, and stretch marks not explained by weight change or pregnancy. Wound healing and scarring are reviewed, as certain scar types point toward other EDS types. Findings help fit or redirect the diagnosis.
How is Hypermobile ehlers-danlos syndrome diagnosed?
Doctors diagnose hypermobile Ehlers-Danlos syndrome mainly through your medical history and a careful exam, checking for widespread joint flexibility, frequent sprains or dislocations, and skin features; many use a simple checklist (the Beighton score) to measure how bendy the joints are. They apply agreed-on criteria that combine joint flexibility, other body signs and long-lasting symptoms, and family history, while ruling out other conditions that affect the body’s support tissues. Blood tests or scans may be used to exclude look-alike problems, and while genetic testing can confirm some other EDS types, there’s currently no single gene test that proves hEDS, so the diagnosis is based on signs and symptoms.
Stages of Hypermobile ehlers-danlos syndrome
Hypermobile ehlers-danlos syndrome does not have defined progression stages. Symptoms often ebb and flow over time—some days are easier, while flare-ups can follow injuries, illness, or stress—so it doesn’t move in a predictable, stepwise way. Doctors usually start with a conversation about your symptoms, past injuries, and family background, then examine joint flexibility and skin features and rule out other causes; there isn’t a single lab or genetic test that confirms hypermobile ehlers-danlos syndrome at this time. Ongoing care usually focuses on tracking early symptoms of hypermobile ehlers-danlos syndrome like joint pain, frequent sprains, or fatigue, along with changes in function, so your team can adjust support and therapy as needed.
Outlook and prognosis
Many people ask, “What does this mean for my future?”, especially after a new diagnosis of hypermobile Ehlers-Danlos syndrome (hEDS). The outlook is not the same for everyone, but most people with hEDS can live a full life span. Pain, fatigue, and joint instability often ebb and flow; you might notice some days are easier, while others require more pacing and supports like braces or taping. When thinking about the future, it helps to know that early care can make a real difference—physical therapy focused on muscle strength and joint control, sleep and pain management, and treatment of dizziness or gut symptoms can reduce flares and prevent injuries.
Prognosis refers to how a condition tends to change or stabilize over time. In hEDS, life-threatening complications are uncommon, and mortality is generally similar to the general population, unlike some other EDS types that affect large blood vessels. That said, ongoing issues—chronic pain, dislocations, pelvic or spinal problems, migraines, or digestive and pelvic floor symptoms—can impact day-to-day function and work or school. Over time, most people find a personalized routine that balances activity, joint protection, and recovery; early symptoms of hypermobile Ehlers-Danlos syndrome may look different from later challenges, which often center on pain control and stamina.
Knowing what to expect can ease some of the worry. With ongoing care, many people maintain steady function, and some even improve as they build strength and learn joint-safe movement. Talk with your doctor about what your personal outlook might look like, including plans for pregnancy, surgery, or sports, and ask how to monitor for related conditions like orthostatic intolerance or mast cell symptoms. If symptoms change suddenly—new severe chest pain, unexplained swelling, or neurological changes—seek urgent care, but remember that serious vascular problems are not typical in hEDS.
Long-term effects
Hypermobile Ehlers-Danlos syndrome can have a shifting long-term picture that affects joints, energy, and several body systems. Long-term effects vary widely, and not everyone has the same mix or intensity. Some features ease over time as joints stiffen with age, while others—like pain or fatigue—can continue or change in character. Here’s what doctors and research know about how the condition may evolve over years.
Repeated sprains, partial dislocations, or full dislocations can continue over time. Some people find joint looseness less obvious with age as stiffness increases, but instability-related injuries may still occur.
Ongoing joint and muscle pain is common and can range from localized to widespread. Pain may flare after activity or minor injuries and can affect sleep and concentration.
Many people report persistent tiredness that is out of proportion to activity. Fatigue can worsen after physical or mental effort and may limit day-to-day endurance.
Wear-and-tear changes in joints can appear earlier than in peers without hEDS. This can bring stiffness, aching, and reduced range of motion over time.
How is it to live with Hypermobile ehlers-danlos syndrome?
Living with hypermobile Ehlers-Danlos syndrome often means planning your day around a body that can feel both flexible and fragile—joints may ache, slip, or tire quickly, and tasks that require grip, posture, or stamina can take extra effort. Many find they pace activities, use braces or supports, and lean on routines that protect joints and manage pain and fatigue, while also navigating flares that can suddenly change plans. Friends, family, and coworkers may notice the need for rest breaks, help with lifting or repetitive tasks, or patience during recovery after minor injuries, and clear communication usually makes teamwork smoother. With the right strategies—physical therapy focused on stability, thoughtful activity choices, and supportive care—people can build a full life while respecting their body’s limits.
Treatment and drugs
Treatment for hypermobile Ehlers-Danlos syndrome (hEDS) focuses on easing symptoms, protecting joints, and maintaining function over time. Physical therapy is the backbone: targeted exercises strengthen the muscles that stabilize loose joints, improve posture, and build balance, while braces or taping may support joints during daily tasks or sports. Pain care often combines over-the-counter pain relievers, heat or cold, gentle stretching, and pacing activities; some may benefit from prescription options, topical treatments, or occasional joint injections, and doctors sometimes recommend a combination of lifestyle changes and drugs. Alongside medical treatment, lifestyle choices play a role: sleep, hydration, salt intake (if advised), and low-impact movement such as swimming or cycling can reduce flares, and occupational therapy can suggest joint‑saving ways to do everyday tasks. It’s common to try more than one medication before finding what helps most, so keep track of how you feel, and share this with your care team.
Can you cure Hypermobile ehlers-danlos syndrome?
There’s currently no cure for hypermobile Ehlers-Danlos syndrome (hEDS). Care focuses on managing symptoms and protecting joints—often with physical therapy and muscle‑strengthening, pain relief, and joint supports or braces, plus help for related issues like fatigue, dizziness, and stomach or bowel troubles. With a tailored plan and steady pacing, many people can lower flare‑ups and improve day‑to‑day function.
Non-drug treatment
Loose, painful joints can turn everyday things—like opening jars or walking the dog—into stop‑and‑go tasks that sap energy. Non-drug treatments often lay the foundation for steadier days by improving joint control, easing pain, and protecting function. For hypermobile Ehlers-Danlos syndrome, care is tailored and usually combines movement training, supports, pain-coping skills, and lifestyle steps. The goals are to reduce flares, protect joints over time, and help you do more of what matters.
A physiotherapist teaches joint‑stabilizing moves and safer movement patterns. Starting when early symptoms of hypermobile Ehlers-Danlos syndrome show up can prevent setbacks. Progress is slow and steady, avoiding end‑range positions.
Low‑impact, controlled strengthening (core, hips, shoulders) builds joint support. Short, frequent sessions work better than occasional hard workouts. Avoid locking joints and increase resistance gradually.
Balance and joint‑position exercises sharpen body awareness. Better control can reduce slips, sprains, and painful over‑stretching. Simple drills can be done at home once learned.
Break tasks into smaller chunks and alternate activity with short rests. Keep track of what triggers flares to plan your day smarter. Try introducing one change at a time, rather than overhauling everything at once.
Your genes may have an impact on how drugs work for you
Genes can affect how your body processes pain medicines, antidepressants for pain modulation, and anesthesia, changing dose needs and side‑effect risks. Pharmacogenetic testing may guide safer choices, but clinical history, joint instability, dysautonomia, and allergies still shape medication plans in hypermobile Ehlers-Danlos syndrome.
Pharmacological treatments
Medicines for hypermobile Ehlers-Danlos syndrome (hEDS) are chosen to target specific symptoms like pain, dizziness from standing, headaches, gut upset, and allergy-type reactions. For many, early symptoms of hypermobile Ehlers-Danlos syndrome such as joint pain and fatigue are managed with simple pain relievers, and other drugs are added if needed. Not everyone responds to the same medication in the same way. Your clinician will usually combine medicine with physical therapy, bracing, hydration, and sleep support.
Acetaminophen/paracetamol and NSAIDs like ibuprofen or naproxen can ease day‑to‑day joint pain and flares. First-line medications are those doctors usually try first, based on safety and track record. Long-term NSAID use may irritate the stomach or kidneys, so dosing and duration are kept as low as possible.
Lidocaine patches, topical diclofenac gel, or capsaicin cream target sore areas with fewer whole‑body side effects. These can help with localized joint or tendon pain common in hEDS. They are useful when oral painkillers aren’t tolerated.
Duloxetine, amitriptyline or nortriptyline, and gabapentin or pregabalin can reduce nerve‑related pain and sleep disruption. Dosing may be increased or lowered gradually to find benefit with minimal side effects. Dry mouth, dizziness, or sleepiness can occur, especially at the start.
Short courses of cyclobenzaprine, tizanidine, or baclofen may help muscle spasms around unstable joints. These are often used at night to improve sleep. Daytime use is limited due to drowsiness and fall risk.
Genetic influences
Many families notice joint hypermobility and related symptoms show up across generations, suggesting a hereditary component to hypermobile Ehlers-Danlos syndrome (hEDS). Family history is one of the strongest clues to a genetic influence. In many families, hEDS seems to follow a dominant pattern—if a parent is affected, each child has up to a 1 in 2 (50%) chance of inheriting the tendency—yet severity can vary widely from one relative to another. Unlike other EDS types, the specific gene (or genes) behind hEDS hasn’t been pinpointed, so genetic testing for hypermobile Ehlers-Danlos syndrome cannot currently confirm the diagnosis. Testing may still be offered to rule out other connective tissue conditions with known gene changes when features overlap. Because the underlying gene is still unknown, diagnosis relies on clinical criteria, and researchers continue to study families to identify the exact genetic cause.
Is Hypermobile ehlers-danlos syndrome genetic?
Genetics likely play a role in hypermobile Ehlers-Danlos syndrome (hEDS), but the exact gene changes are still unclear for most people. hEDS often runs in families, suggesting inherited susceptibility. Genetic testing rarely confirms hEDS; diagnosis relies on clinical evaluation.
Having a genetic risk is not necessarily a diagnosis
Genetic variants occur naturally in humans and are widespread across the population. The vast majority do not affect health and simply reflect normal human variation. For many genes, having a variant tied to a condition suggests a possible link rather than a certain diagnosis, especially when multiple genes and environmental factors are involved. Even so, in some situations a single well-studied variant in a particular gene can be enough to confirm a diagnosis.
Pharmacogenetics—how genetics influence drug effects
For people with hypermobile Ehlers-Danlos syndrome (hEDS), care usually targets symptoms like pain, poor sleep, stomach upset, and fast heart rate or dizziness. Because medicines are used from several areas—pain relievers, antidepressants used for nerve pain, anti-inflammatory drugs, beta-blockers, and acid-reducing medicines—differences in genes that guide liver enzymes can change how well each option works and how likely side effects are. That’s why two people with hEDS can take the same drug and one feels better while the other feels foggy, nauseated, or barely helped.
Genetic testing can sometimes identify how your body handles medicines such as codeine or tramadol, certain antidepressants used for pain (like amitriptyline or duloxetine), beta-blockers like metoprolol, or some anti-inflammatory medicines, which can inform dose choices or a switch to a better-matched alternative. If your body converts codeine or tramadol slowly, pain relief may be weak; if it converts them very quickly, side effects can show up at standard doses, and similar patterns apply to some antidepressants and anti-inflammatories. Pharmacogenetic testing for hypermobile Ehlers-Danlos syndrome doesn’t diagnose hEDS or replace trying treatments step-by-step, but it can add helpful context alongside your history, other health conditions such as POTS, and the other medicines you take.
Interactions with other conditions
Day to day, hypermobile Ehlers-Danlos syndrome can intersect with other health issues in ways that shape energy, comfort, and routines. Dizziness, rapid heartbeat, and heat intolerance from autonomic problems such as postural orthostatic tachycardia syndrome (POTS) often ride along with joint pain and fatigue, and each can make the other feel more intense. Doctors call it a “comorbidity” when two conditions occur together. Many living with hypermobile Ehlers-Danlos syndrome also report irritable bowel symptoms, reflux, or constipation, and these gut issues can flare during pain spikes or when mobility is limited.
Headaches and migraine are common partners, and chronic pain conditions like fibromyalgia may overlap, complicating sleep and mood but not meaning symptoms are “all in your head.” Pelvic floor problems, hernias, and organ prolapse can occur more easily when tissues are looser, sometimes worsening bladder or bowel symptoms. Early symptoms of hypermobile Ehlers-Danlos syndrome can blend with signs of these other conditions, which can delay a clear diagnosis. Interactions can look very different from person to person, so coordinated care—often involving cardiology, gastroenterology, pain management, and physical therapy—helps tailor treatment to what matters most in daily life.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
What other conditions can cause similar symptoms to Hypermobile ehlers-danlos syndrome?
Symptoms similar to hypermobile Ehlers-Danlos syndrome can also appear in people with hypermobility spectrum disorders (HSD), where joints are very flexible and painful but the full hEDS pattern isn’t present. Other inherited connective tissue conditions such as Marfan syndrome and Loeys-Dietz syndrome, and other types of Ehlers-Danlos (classical or vascular), can also show very flexible joints and stretchy skin and may involve the heart and blood vessels. Widespread pain and tiredness from fibromyalgia, and joint pain from inflammatory arthritis (like rheumatoid arthritis or lupus), can also look similar at first.
History
Throughout history, people have described family members who could bend far beyond the usual range, bruise easily, or had joints that “gave way” during everyday tasks. Community stories often mentioned flexible kids who wowed at school events but later struggled with aching joints or frequent sprains. Looking back, these accounts echo what we now recognize as hypermobile Ehlers-Danlos syndrome (hEDS).
First described in the medical literature as part of a broader group of “Ehlers-Danlos” conditions in the early 20th century, the hypermobile form was initially grouped with other types because many shared loose joints and stretchy skin. Over time, descriptions became more precise. Doctors noticed that people with hEDS often had joint instability, pain, and soft-tissue injuries without the fragile blood vessels or significant scarring seen in some other subtypes. This careful sorting helped separate hEDS from look‑alike conditions.
From early theories to modern research, the story of hypermobile Ehlers-Danlos syndrome reflects changing tools and understanding. Before genetic testing, clinicians relied on patterns in families, physical exams, and skin and joint features. Advances in genetics clarified several EDS types by pinpointing gene changes, but a single, consistent genetic cause for most people with hEDS has not yet been identified. That absence shaped the history of diagnosis: criteria were based on clinical features and family history rather than a lab test.
In recent decades, knowledge has built on a long tradition of observation. International groups refined diagnostic checklists to improve consistency across clinics and countries. These updates aimed to balance two needs: recognizing people with clear, early symptoms of hEDS while avoiding over- or under-diagnosis. The most recent criteria emphasize a combination of generalized joint hypermobility, typical tissue signs, pain or instability, and exclusion of other conditions.
Understandings have changed, but the lived experience has been consistent in the stories passed down: frequent sprains, slow‑to‑heal soft‑tissue injuries, and fatigue that doesn’t match the activity level. For many, this meant long stretches of uncertainty before getting a name for what was happening. Growing awareness among physiotherapists, primary care clinicians, and rheumatologists has shortened that path for some, and encouraged earlier, tailored management.
Today, the history of hypermobile Ehlers-Danlos syndrome is still unfolding. Researchers are mapping subtle biological pathways, studying how hEDS runs in families, and refining how we measure joint laxity and tissue changes over time. Knowing the condition’s history helps explain why diagnosis relies on clinical criteria and why care often centers on practical supports—like targeted strengthening, joint protection, and pain strategies—while science works toward clearer genetic answers.